EndoCeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EndoCeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10809
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company’s pipeline products include drugs for various indications such as endometriosis, male hypogonadism and antiandrogens, among others. It develops non estrogen-based therapies for vulvovaginal atrophy, sexual dysfunction and the other symptoms of menopause that includes osteoporosis, hot flushes, muscle loss and diabetes. EndoCeutics’ hormonal therapies used for the treatment of uterine, breast, and prostate cancer, and endometriosis are under development. It also offers analytical, bio-analytical and other research and development services. The company operates laboratory in Quebec. EndoCeutics is headquartered in Quebec, Canada.

EndoCeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EndoCeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sermonix Pharma Raises USD4.2 Million in Seed Financing 10
Sermonix Pharma Raises USD4.2 Million in Seed Preferred Equity Bridge Financing 11
Partnerships 12
Veristat Extends Partnership with EndoCeutics 12
Licensing Agreements 13
Theramex Enters into Licensing Agreement with Endoceutics 13
Mundipharma Enters into Licensing Agreement with Endoceutics 14
AMAG Pharma and Endoceutics Pharma Enter into Licensing Agreement 15
EndoCeutics Inc – Key Competitors 16
EndoCeutics Inc – Key Employees 17
EndoCeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Product News 19
07/24/2017: AMAG Pharmaceuticals Launches Intrarosa (prasterone) in the U.S. – a Novel Product to Treat Moderate to Severe Dyspareunia Due to Menopause 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
EndoCeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EndoCeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EndoCeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sermonix Pharma Raises USD4.2 Million in Seed Financing 10
Sermonix Pharma Raises USD4.2 Million in Seed Preferred Equity Bridge Financing 11
Veristat Extends Partnership with EndoCeutics 12
Theramex Enters into Licensing Agreement with Endoceutics 13
Mundipharma Enters into Licensing Agreement with Endoceutics 14
AMAG Pharma and Endoceutics Pharma Enter into Licensing Agreement 15
EndoCeutics Inc, Key Competitors 16
EndoCeutics Inc, Key Employees 17
EndoCeutics Inc, Other Locations 18
EndoCeutics Inc, Subsidiaries 18

List of Figures
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[EndoCeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bosideng International Holdings Limited
    Bosideng International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Bosideng International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Marr S.P.A.
    Marr S.P.A. - Strategy, SWOT and Corporate Finance Report Summary Marr S.P.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Gol Linhas Aereas Inteligentes SA :企業の戦略・SWOT・財務情報
    Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report Summary Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Vygon SA:医療機器:M&Aディール及び事業提携情報
    Summary Vygon SA (Vygon) is a medical specialty company that designs, manufactures and markets single use medical and surgical products. The company offers products in various specialties such as paediatrics, neonatology, support for post-operative pain relief, anesthesia, emergency and intensive ca …
  • ConceptoMed AS-医療機器分野:企業M&A・提携分析
    Summary ConceptoMed AS (ConceptoMed) is a medical device manufacturer that offers medtech products. The company's products comprise medical syringe and needle, medical tools, Luer-Jack, ConceptoShield, and disposable medical instruments and devices. ConceptoMed also offers epidural injections, plexu …
  • Alabama Power Co:企業の発電所・SWOT分析2018
    Alabama Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Actelion Ltd:企業の戦略・SWOT・財務情報
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Leukemia & Lymphoma Society Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary The Leukemia & Lymphoma Society Inc (LLS) is a voluntary health organization that focuses on funding research for identifying cure for blood cancer. The organization also assures access to treatments for blood cancer patients. Its offers patient support, health education, policy advocacy, an …
  • Arcturus Therapeutics Ltd (ARCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Arcturus Therapeutics Ltd (Arcturus), formerly Alcobra Ltd is a pharmaceutical company that develops a portfolio of nucleic acid therapeutics for treatment of diseases with unmet medical needs. It discovers and develops RNA medicines and design and utilize lipid-mediated drug delivery system …
  • Viscom AG (V6C):企業の財務・戦略的SWOT分析
    Viscom AG (V6C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • The Nippon Synthetic Chemical Industry Co Ltd:企業の戦略的SWOT分析
    The Nippon Synthetic Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Jun Yang Financial Holdings Ltd:企業のM&A・事業提携・投資動向
    Jun Yang Financial Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Jun Yang Financial Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • St. George’s University of London-製薬・医療分野:企業M&A・提携分析
    Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider that offers undergraduate and post graduate courses. The university’s undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthc …
  • CapitaLand Limited:企業のM&A・事業提携・投資動向
    CapitaLand Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CapitaLand Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Tallgrass Energy Partners, LP (TEP)-石油・ガス分野:企業M&A・提携分析
    Summary Tallgrass Energy Partners, LP (Tallgrass Energy) is a midstream oil and gas company. It owns, operates, acquires and develops midstream energy assets in North America. The company offers natural gas transportation and storage services through its pipeline and natural gas processing assets to …
  • Reliance Industries Limited:企業の戦略・SWOT・財務分析
    Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Magnitogorsk Iron & Steel Works:企業の戦略・SWOT・財務情報
    Magnitogorsk Iron & Steel Works - Strategy, SWOT and Corporate Finance Report Summary Magnitogorsk Iron & Steel Works - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bank Alfalah Ltd:企業の戦略・SWOT・財務情報
    Bank Alfalah Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank Alfalah Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NorthWestern Corporation (NWE)-石油・ガス分野:企業M&A・提携分析
    Summary NorthWestern Corporation, doing business as NorthWestern Energy, is an integrated electric utility which generates, transmits, and distributes electricity and distributes natural gas in South Dakota, Nebraska and Montana. It produces energy from wind, hydro, natural gas, and coal-fired sourc …
  • Ashapura Minechem Ltd.:企業の戦略・SWOT・財務分析
    Ashapura Minechem Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ashapura Minechem Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆